Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control.

Hala Joharji,Delal Alkortas,Aziza Ajlan,Mohamed Ahmed,Hamad Al-Ashgar,Mohammed Al-Quaiz,Dieter Broering,Mohammed Al-Sebayel,Hussien Elsiesy,Faisal A Alkhail,Waleed K Al-Hamoudi,Edward De Vol, Epi Amirah Almuhayshir,Ahmed Al-Jedai

Health science reports（2023）

引用 1|浏览24

暂无评分

摘要

Generic sofosbuvir combined with branded daclatasvir was safe and effective for treating genotype 4 HCV compared to Sof-Led. This combination may significantly reduce the cost burden, enabling a larger pool of treated patients. Office of research affairs at KFSHRC RAC# 2171 036.

查看译文

关键词

cost saving,direct acting antivirals,sustained virological response,viral hepatitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要